# Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs

> **NCT06641596** · NA · COMPLETED · sponsor: **Kerry Group P.L.C** · enrollment: 112 (actual)

## Conditions studied

- Overweight
- Metabolic Syndrome X

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Cr-400
- **DIETARY_SUPPLEMENT:** Cr-800
- **DIETARY_SUPPLEMENT:** PE-500
- **DIETARY_SUPPLEMENT:** PE-1000

## Key facts

- **NCT ID:** NCT06641596
- **Lead sponsor:** Kerry Group P.L.C
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2024-01-30
- **Final completion:** 2024-05-29
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06641596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06641596, "Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06641596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*